12-80302695-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378609.3(OTOGL):​c.3125A>G​(p.Tyr1042Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00554 in 1,515,082 control chromosomes in the GnomAD database, including 392 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 217 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 175 hom. )

Consequence

OTOGL
NM_001378609.3 missense

Scores

4
6
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 8.43

Publications

1 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036207438).
BP6
Variant 12-80302695-A-G is Benign according to our data. Variant chr12-80302695-A-G is described in ClinVar as Benign. ClinVar VariationId is 226937.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0977 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.3125A>G p.Tyr1042Cys missense_variant Exon 28 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.3125A>G p.Tyr1042Cys missense_variant Exon 28 of 59 5 NM_001378609.3 ENSP00000447211.2
OTOGLENST00000646859.1 linkc.2990A>G p.Tyr997Cys missense_variant Exon 32 of 63 ENSP00000496036.1

Frequencies

GnomAD3 genomes
AF:
0.0287
AC:
4372
AN:
152184
Hom.:
217
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.100
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0100
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.00716
AC:
1124
AN:
156942
AF XY:
0.00515
show subpopulations
Gnomad AFR exome
AF:
0.0953
Gnomad AMR exome
AF:
0.00567
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000321
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000297
Gnomad OTH exome
AF:
0.00401
GnomAD4 exome
AF:
0.00295
AC:
4016
AN:
1362780
Hom.:
175
Cov.:
29
AF XY:
0.00255
AC XY:
1716
AN XY:
673262
show subpopulations
African (AFR)
AF:
0.103
AC:
3187
AN:
31032
American (AMR)
AF:
0.00578
AC:
195
AN:
33734
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24170
East Asian (EAS)
AF:
0.000324
AC:
12
AN:
37062
South Asian (SAS)
AF:
0.0000968
AC:
7
AN:
72296
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35686
Middle Eastern (MID)
AF:
0.00153
AC:
8
AN:
5240
European-Non Finnish (NFE)
AF:
0.000190
AC:
203
AN:
1066814
Other (OTH)
AF:
0.00712
AC:
404
AN:
56746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
171
342
512
683
854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0288
AC:
4385
AN:
152302
Hom.:
217
Cov.:
32
AF XY:
0.0277
AC XY:
2062
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.100
AC:
4163
AN:
41542
American (AMR)
AF:
0.0100
AC:
153
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000397
AC:
27
AN:
68036
Other (OTH)
AF:
0.0194
AC:
41
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
206
412
619
825
1031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00534
Hom.:
76
Bravo
AF:
0.0324
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0951
AC:
343
ESP6500EA
AF:
0.000246
AC:
2
ExAC
AF:
0.00762
AC:
898
Asia WGS
AF:
0.00405
AC:
14
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 23, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Tyr1033Cys in exon 27 of OTOGL: This variant is not expected to have clinical si gnificance because it has been identified in 9.5% (343/3608) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs12304169).

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.65
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Uncertain
0.060
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0
.;.;.
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.92
D;.;D
MetaRNN
Benign
0.0036
T;T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
0.0
.;.;.
PhyloP100
8.4
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
0.0
.;.;D
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;.;D
Sift4G
Pathogenic
0.0
.;.;D
Vest4
0.0
ClinPred
0.035
T
GERP RS
5.7
gMVP
0.96
Mutation Taster
=77/23
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12304169; hg19: chr12-80696475; API